FDA.reportPublic FDA data

Ogsiveo 100 MG Tablet 7-Day 14 Count Pack

RxCUI
2680364
RxNorm name
Ogsiveo 100 MG Tablet 7-Day 14 Count Pack
Display name
Ogsiveo 100 MG Tablet 7-Day 14 Count Pack
Full name
Ogsiveo 100 MG Tablet 7-Day 14 Count Pack
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:27

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
OGSIVEONIROGACESTATSpringWorks Therapeutics, Inc.f172e6ff-3190-41b0-b95a-58a7ef9e9e1e2026-09-01Warnings, Adverse reactionsExact identifier
rxcui: 2680364

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
f172e6ff-3190-41b0-b95a-58a7ef9e9e1e{14 (nirogacestat 100 MG Oral Tablet [Ogsiveo]) } Pack [Ogsiveo 100 MG 7-Day] [BPCK] · Ogsiveo 100 MG Tablet 7-Day 14 Count Pack [PSN] · Ogsiveo 100 MG Tablet 7-Day 14 Count Pack [SY]314These highlights do not include all the information needed to use OGSIVEO safely and effectively. See full prescribing information for OGSIVEO. OGSIVEO ® (nirogacestat) tablets, for oral use Initial U.S. Approval: 202320260326